{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:49:58Z","timestamp":1791103798559,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1378\/chest.128.3.1401","type":"journal-article","created":{"date-parts":[[2005,9,14]],"date-time":"2005-09-14T17:04:24Z","timestamp":1126717464000},"page":"1401-1405","source":"Crossref","is-referenced-by-count":125,"title":["Fluoroquinolones vs Macrolides in the Treatment of Legionnaires Disease"],"prefix":"10.1016","volume":"128","author":[{"given":"Miquel","family":"Sabri\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Pedro-Botet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Roig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Vilaseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nieves","family":"Sopena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Ba\u00f1os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.128.3.1401_bib1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev.me.31.020180.001251","article-title":"Legionnaires\u2019 disease","volume":"31","author":"Meyer","year":"1980","journal-title":"Annu Rev Med"},{"key":"10.1378\/chest.128.3.1401_bib2","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1097\/00007611-198111000-00036","article-title":"Failure of oral erythromycin therapy for Legionnaires\u2019 disease in a renal transplant recipient","volume":"74","author":"Hays","year":"1981","journal-title":"South Med J"},{"key":"10.1378\/chest.128.3.1401_bib3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0163-4453(85)92838-5","article-title":"Failure of erythromycin\/rifampicin treatment of Legionella pneumonia","volume":"10","author":"Mercatello","year":"1985","journal-title":"J Infect"},{"key":"10.1378\/chest.128.3.1401_bib4","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0002-9343(84)90793-9","article-title":"Failure of erythromycin in treatment ofLegionella micdadeipneumonia","volume":"76","author":"Rudin","year":"1984","journal-title":"Am J Med"},{"key":"10.1378\/chest.128.3.1401_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/jac\/41.2.289","article-title":"Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristine\/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells","volume":"41","author":"Stout","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.128.3.1401_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0732-8893(97)00174-0","article-title":"Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells","volume":"30","author":"Stout","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1378\/chest.128.3.1401_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1469-0691.1999.tb00125.x","article-title":"In vitroactivity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species","volume":"5","author":"Dubois","year":"1999","journal-title":"Clin Microbiol Infect"},{"key":"10.1378\/chest.128.3.1401_bib8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1128\/AAC.43.1.90","article-title":"In vitroactivity of the ketolide HMR 3647 (TU6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs withLegionella pneumophilapneumonia","volume":"43","author":"Edelstein","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1378\/chest.128.3.1401_bib9","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1128\/AAC.42.6.1520","article-title":"Susceptibilities of Legionella spp. to newer antimicrobialsin vitro","volume":"42","author":"Sch\u00fclin","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1378\/chest.128.3.1401_bib10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0934-8840(97)80009-6","article-title":"Excellent activity of newer quinolones onLegionella pneumophilain J 774 macrophages","volume":"285","author":"Walz","year":"1997","journal-title":"Zentralbl Bakteriol"},{"key":"10.1378\/chest.128.3.1401_bib11","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1128\/AAC.33.12.2132","article-title":"WIN 57273 is bactericidal forLegionella pneumophilagrown in alveolar macrophages","volume":"33","author":"Edelstein","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1378\/chest.128.3.1401_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jac\/37.1.117","article-title":"In vitroactivity of levofloxacin against clinical isolates of Legionella spp., its pharmacokinetics in guinea pigs, and use in experimentalLegionella pneumophilapneumonia","volume":"37","author":"Edelstein","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.128.3.1401_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/AAC.28.1.15","article-title":"Susceptibility ofLegionella pneumophilato ofloxacinin vitroand in experimental Legionella pneumonia in guinea pigs","volume":"28","author":"Saito","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1378\/chest.128.3.1401_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0732-8893(97)00174-0","article-title":"Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells","volume":"30","author":"Stout","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1378\/chest.128.3.1401_bib15","first-page":"291","article-title":"Traitement des l\u00e9gionelloses par ofloxacine chez le transplant renal: abscence d\u2019interf\u00e9rence avec la ciclosporine A","volume":"20","author":"Wynkel","year":"1991","journal-title":"Presse Med"},{"key":"10.1378\/chest.128.3.1401_bib16","doi-asserted-by":"crossref","first-page":"128S","DOI":"10.1016\/0002-9343(89)90041-7","article-title":"Ciprofloxacin in the treatment of legionellosis in critically ill patients including those cases unresponsive to erythromycin","volume":"87(Suppl)","author":"Unertl","year":"1989","journal-title":"Am J Med"},{"key":"10.1378\/chest.128.3.1401_bib17","first-page":"126","article-title":"Brote epid\u00e9mico de neumon\u00eda porLegionella pneumophilaen Murcia 2001","volume":"202(Suppl)","author":"Barrio","year":"2002","journal-title":"Rev Clin Esp"},{"key":"10.1378\/chest.128.3.1401_bib18","first-page":"474","article-title":"Legionella spp. pneumonia in patients with hematologic diseases: a study of 10 episodes from a series of 67 cases of pneumonia","volume":"84","author":"Fernandez-Avil\u00e9s","year":"1999","journal-title":"Hematologica"},{"key":"10.1378\/chest.128.3.1401_bib19","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1056\/NEJM199709043371006","article-title":"Current concepts: legionellosis","volume":"337","author":"Stout","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.128.3.1401_bib20","first-page":"955","article-title":"Unresponsiveness ofLegionella bozemaniipneumonia to erythromycin administration despitein vitrosusceptibility","volume":"128","author":"Parker","year":"1983","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.128.3.1401_bib21","first-page":"395","article-title":"Legionella species (Legionnaires\u2019 disease)","author":"Sabri\u00e0","year":"2002","journal-title":"Antimicrobial therapy and vaccines"},{"key":"10.1378\/chest.128.3.1401_bib22","article-title":"In vitroactivities of seven quinolones and two macrolides against Legionella isolates [abstract no E2284]","author":"Manzor","year":"1999","journal-title":"Program and Abstracts of the 1999 International Conference on Antimicrobial Agents and Chemotherapy"},{"key":"10.1378\/chest.128.3.1401_bib23","article-title":"Treatment with levofloxacin of community-acquired pneumonia caused by Legionella spp [abstract no P846]","author":"Sanchez-Conde","year":"2001","journal-title":"Program and Abstracts of the 2001 European Congress of Clinical Microbiology and Infectious Diseases"},{"key":"10.1378\/chest.128.3.1401_bib24","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1378\/chest.124.2.543","article-title":"Legionnaires\u2019 disease and HIV infection","volume":"124","author":"Pedro-Botet","year":"2003","journal-title":"Chest"},{"key":"10.1378\/chest.128.3.1401_bib25","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1093\/clind\/21.Supplement_3.S265","article-title":"Antimicrobial chemotherapy for Legionnaires\u2019 disease: a review","volume":"21","author":"Edelstein","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.128.3.1401_bib26","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/clinids\/17.3.518","article-title":"Unsuccessful treatment ofLegionella pneumophilainfection with a fluoroquinolone","volume":"17","author":"Salord","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.128.3.1401_bib27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jac\/22.3.389","article-title":"Failure of treatment ofLegionella pneumophilawith ciprofloxacin","volume":"22","author":"Kurz","year":"1988","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.128.3.1401_bib28","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1111\/j.1469-0691.1998.tb00692.x","article-title":"Pharmacokinetics and pharmacodynamics of fluoroquinolones","volume":"4","author":"Drusano","year":"1998","journal-title":"Clin Microbiol Infect"},{"key":"10.1378\/chest.128.3.1401_bib29","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1128\/AAC.42.12.3153","article-title":"Antibacterial effects of levofloxacin, erythromycin, and rifampin in a human monocyte system againstLegionella pneumophila.","volume":"42","author":"Baltch","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1378\/chest.128.3.1401_bib30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1086\/516258","article-title":"Role of immunosuppression in the evolution of Legionnaires\u2019 disease","volume":"26","author":"Pedro-Botet","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.128.3.1401_bib31","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF01695659","article-title":"Delay in appropriate therapy of Legionella pneumonia associated with increased mortality","volume":"15","author":"Heath","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1378\/chest.128.3.1401_bib32","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s00134-002-1304-8","article-title":"Severe pneumonia due toLegionella pneumophila: prognostic factors, impact of delayed appropriate antimicrobial therapy","volume":"28","author":"Gacouin","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1378\/chest.128.3.1401_bib33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jac\/26.suppl_B.129","article-title":"Comparison of the activity of three antibiotic regimens in severe Legionnaires\u2032 disease","volume":"26(Suppl)","author":"Dournon","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.128.3.1401_bib34","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-129-4-199808150-00012","article-title":"Antimicrobial chemotherapy for Legionnaires\u2032 disease: time for a change","volume":"129","author":"Edelstein","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.128.3.1401_bib35","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/jac\/dkg191","article-title":"Legionnaires\u2019 disease: a rational approach to therapy","volume":"51","author":"Roig","year":"2003","journal-title":"J Antimicrob Chemother"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236921552165X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236921552165X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T12:47:30Z","timestamp":1553258850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001236921552165X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S001236921552165X"],"URL":"https:\/\/doi.org\/10.1378\/chest.128.3.1401","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}